Intranasal Delivery of Brain‐Derived Neurotrophic Factor (BDNF)‐Loaded Small Extracellular Vesicles for Treating Acute Spinal Cord Injury in Rats and Monkeys
Journal of Extracellular Vesicles · 2025-04 · 14 (4)
DOI: 10.1002/jev2.70066 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Extracellular Vesicles, online erschienen am 07.04.2025. Verfasst von Zhonghai Huang und 18 weiteren Autor:innen. Beteiligte Einrichtung: Guangdong Provincial Key Laboratory of Spine and Spinal Cord Reconstruction, The Fifth Affiliated Hospital (Heyuan Shenhe People's Hospital), Jinan U…. Hauptthemen laut MEDLINE: Brain-Derived Neurotrophic Factor, Spinal Cord Injuries, Extracellular Vesicles. Die Arbeit wurde bisher 46-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Guangzhou Key Projects of Brain Science and Brain-Like Intelligence Technology, National Key R and D Program of China, Guangdong grant 'Key Technologies for Treatment of Brain Disorders'.
Abstract (Originalsprache)
Besides surgical decompression, neuroprotection and neuroinflammation reduction are critical for acute spinal cord injury (SCI). In this study, we prepared small extracellular vesicles (sEVs) from immortalised mesenchymal stem cells overexpressing brain‐derived neurotrophic factor (BDNF) and evaluated whether intranasal administration of BDNF‐sEVs is a therapeutic option for acute SCI. In cultured neurons, BDNF loading enhanced neurite outgrowth promoted by sEVs. After intranasal administration, mCherry‐labelled sEVs were transported to the injured spinal cords of rats and monkeys and mainly taken up by neurons. In acute SCI rats, intranasal administration of sEVs and BDNF‐sEVs reduced glial responses and proinflammatory cytokine production, enhanced neuronal survival and angiogenesis in the lesion, promoted injured axon rewiring, delayed lumbar spinal motoneuron atrophy below the lesion, and improved functional performance. The rats receiving BDNF‐sEV treatment showed improved neural repair and functional recovery compared to those with sEV treatment. Intranasal administration of BDNF‐sEVs, but not of sEVs, increased BDNF levels and phosphorylation of downstream signals in the rat‐injured spinal cord samples, indicating activation of the BDNF/TrkB signalling pathway. In acute SCI monkeys, intranasal administration of BDNF‐sEVs was further confirmed to inhibit glial reactivities and proinflammatory cytokine release, increasing BDNF levels in the cerebrospinal fluid, enhancing neural network rewiring of injured spinal cords and neuronal activities of the brain, and improving functional performances in behavioural tests and electrophysiological recordings. In conclusion, BDNF‐sEVs play a combinatory therapeutic role of sEVs and BDNF, and intranasal administration of BDNF‐sEVs is a potential option for the clinical treatment of acute SCI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Guangdong Provincial Key Laboratory of Spine and Spinal Cord Reconstruction, The Fifth Affiliated Hospital (Heyuan Shenhe People's Hospital), Jinan University, Heyuan, China.
- Guangdong-Hongkong-Macau Institute of CNS Regeneration, Key Laboratory of CNS Regeneration (Jinan University)-Ministry of Education, Guangdong Key Laboratory of Non-Human Primate Research, Jinan University, Guangzhou, C…
- Department of Orthopedics, The First Affiliated Hospital, Jinan University, Guangzhou, China.
- Department of Human Anatomy, The College of Basic Medical Sciences, Jinan University, Guangzhou, China.
- Otorhinolaryngology Hospital of The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
- Extracellular Vesicle Research and Clinical Translational Center, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China.
ORCID-Profile: Zhonghai Huang
Förderung
- Guangzhou Key Projects of Brain Science and Brain-Like Intelligence Technology
- National Key R and D Program of China
- Guangdong grant 'Key Technologies for Treatment of Brain Disorders'
- National Natural Science Foundation of China
- Programme of Introducing Talents of Discipline to Universities
Zitieren
APA
Huang, Z., Li, J., Wo, J., Li, C. L., Wu, Z. C., Deng, X. H., Liang, Y., Li, F., Chen, B., Jia, B., Wang, L., Wang, Y., Sun, G., Li, Z., Zhu, H., Guest, J. D., So, K. F., Fu, Q. L., & Zhou, L. (2025). Intranasal Delivery of Brain‐Derived Neurotrophic Factor (BDNF)‐Loaded Small Extracellular Vesicles for Treating Acute Spinal Cord Injury in Rats and Monkeys. Journal of Extracellular Vesicles, 14(4). https://doi.org/10.1002/jev2.70066
Vancouver
Huang Z, Li J, Wo J, Li CL, Wu ZC, Deng XH, et al. Intranasal Delivery of Brain‐Derived Neurotrophic Factor (BDNF)‐Loaded Small Extracellular Vesicles for Treating Acute Spinal Cord Injury in Rats and Monkeys. Journal of Extracellular Vesicles. 2025;14(4). doi:10.1002/jev2.70066
BibTeX
@article{Huang2025,
author = {Huang, Zhonghai and Li, Jing and Wo, Jin and Li, Cheng-Lin and Wu, Zi-Cong and Deng, Xiao-Hui and Liang, Yaying and Li, Fuxiang and Chen, Boli and Jia, Bin and Wang, Lu and Wang, Ying and Sun, Guodong and Li, Zhizhong and Zhu, Hui and Guest, James D and So, Kwok-Fai and Fu, Qing-Ling and Zhou, Libing},
title = {Intranasal Delivery of Brain‐Derived Neurotrophic Factor (BDNF)‐Loaded Small Extracellular Vesicles for Treating Acute Spinal Cord Injury in Rats and Monkeys},
journal = {Journal of Extracellular Vesicles},
year = {2025},
volume = {14},
number = {4},
doi = {10.1002/jev2.70066}
}
EUVIMED